Midday movers: Kohl's, Foot Locker, Peloton and more

  • Investing.com
  • Stock Market News
Midday movers: Kohl's, Foot Locker, Peloton and more

Investing.com -- U.S. stocks were rising as investors anticipated an update on artificial intelligence from Nvidia (NASDAQ: NVDA ), which reports earnings after the closing bell.

Here are some of the biggest U.S. stock movers today:

  • Kohl’s (NYSE: KSS ) stock rose 3.9% after the department store operator beat quarterly profit estimates, as leaner inventories, lower costs, and fewer discounts helped to counter a broader retail slowdown.

  • Foot Locker (NYSE: FL ) stock slumped 30% after the sportswear retailer reported another quarter of falling sales, paused quarterly dividends, and slashed its outlook for the second time this year, blaming “consumer softness.”

  • Peloton (NASDAQ: PTON ) stock slumped 24% after the exercise bike retailer forecast first-quarter revenue below estimates as a shift in consumer spending toward travel and experiences hurt demand for its equipment.
  • Urban Outfitters (NASDAQ: URBN ) stock rose 2.2% after the apparel retailer beat expectations for the second quarter as same-store sales rose, driven by growth in retail stores and online sales.

  • La-Z-Boy (NYSE: LZB ) stock fell 1.6% after the furniture manufacturer said the industry will remain "challenged," with a potential seasonal boost.

  • Toll Brothers (NYSE: TOL ) stock rose 3.4% after the homebuilder beat expectations for third-quarter profit, as demand for luxury homes in a tighter resale market boosted new home sales.

  • WeWork (NYSE: WE ) stock fell 14.8% after the New York Stock Exchange suspended trading in the workspace provider's warrants.

  • Stellantis (NYSE: STLA ) stock rose 0.3% after Bloomberg News reported that the auto giant is exploring options to partner with a Chinese electric vehicle maker as it tries to expand its presence in the world's largest auto market.

  • Apellis Pharmaceuticals (NASDAQ: APLS ) stock soared 31% after the biopharmaceutical company provided a key safety update about its injection kits and the rare events of retinal vasculitis related to its eye drug, Syfovre.

  • AMC Entertainment (NYSE: AMC ) stock fell 10%, continuing to drop after the approval of a rescue deal that will allow the deeply indebted cinema chain to issue more shares.

-- Peter Nurse contributed to this report

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or